CERBA EUROPEAN LAB S.A.S. announces launch of offerings of €85 million in aggregate principal amount of 7.00% senior secured notes
and €145 million in aggregate principal amount of senior notes.

CERBA EUROPEAN LAB S.A.S. announces the closing of the NOVESCIA acquisition.

Bioponant, located in Brest and its region, joined the Cerba European Lab network this summer.

Cerba HealthCare S.A.S. (“Cerba” or the “Group”) today announces that it has successfully priced a private placement of €40 million aggregate principal amount of additional 7.00% Senior Secured Notes due 2020 directly with certain investors.

CERBA HEALTHCARE has announced the acquisition of ANTAGENE, a major player in veterinary genetics, consolidating its position in the veterinary diagnosis sector.

PAI Partners, a leading European private equity firm has entered exclusive negotiations with Partners Group, the global private markets investment manager, and the Public Sector Pensions Investment Board (“PSP Investments”), one of Canada’s largest pension investment managers, for the sale of Cerba HealthCare.

Cerba HealthCare is announcing the acquisition of DELTAMEDICA, a medical group located in Northern Italy in the Milan region.

Cerba HealthCare S.A.S announces preliminary financial results for year end 2016 and expected redemption of existing notes.

Cerba HealthCare - Launch Press Release

Conditional notice of redemption.